Calhm1 p86l polymorphism is associated with late - Onset Alzheimer's disease in a recessive model

Journal of Alzheimer's Disease

Volumn 20, Issue 1, 2010, Pages 247-251

  Boada, Mercè ^a,b   Antúnez, Carmen ^c,d   López Arrieta, Jesús ^e   Galán, José Jorge ^f   Morón, Francisco J ^f   Hernández, Isabel ^a   Marín, Juan ^c   Martínez Lage, Pablo ^a   Alegret, Montserrat ^a   Carrasco, Jose M ^f   Moreno, Concha ^f   Real, Luis M ^f   González Pérez, Antonio ^f   Tárraga, Lluís ^a,b   Ruiz, Agustín ^f  

^a Institut Catala de Neurociencies Aplicades   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^d Alzheimur Foundation   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f NeoCodex ^*  (Spain)

Author keywords

Alzheimer's disease; association; CALHM1; genotype; meta analysis; molecular genetics; polymorphism

Indexed keywords

CALCIUM HOMEOSTASIS REGULATOR 1; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE REPLICATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77954510763     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1357     Document Type: Article

References (11)

1. Dreses-Werringloer U, Lambert JC,VingtdeuxV, Zhao H,Vais H, Siebert A, Jain A, Koppel J, Rovelet-Lecrux A, Hannequin D, Pasquier F, Galimberti D, Scarpini E, Mann D, Lendon C, Campion D, Amouyel P, Davies P, Foskett JK, Campagne F, Marambaud P (2008) A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell 133, 1149-1161.
2. Bertram L, Schjeide BM, Hooli B, Mullin K, Hiltunen M, Soininen H, Ingelsson M, Lannfelt L, Blacker D, Tanzi RE (2008) No association between CALHM1 and Alzheimer's disease risk. Cell 135, 993-994; author reply 994-996.
3. Sleegers K, Brouwers N, Bettens K, Engelborghs S, van Miegroet H, De Deyn PP, Van Broeckhoven C (2009) No association between CALHM1 and risk for Alzheimer dementia in a Belgian population. Hum Mutat 30, E570-E574.
4. Minster RL, Demirci FY, DeKosky ST, Kamboh MI (2009) No association betweenCALHM1variation and risk of Alzheimer disease. Hum Mutat 30, E566-E569.
5. Beecham GW, Schnetz-Boutaud N, Haines JL, Pericak-Vance MA (2009) CALHM1 polymorphism is not associated with late-onset Alzheimer disease. Ann Hum Genet 73, 379-381.
6. Tan EK, Ho P, Cheng SY, Yih Y, Li HH, Fook-Chong S, Lee WL, Zhao Y (2009) CALHM1 variant is not associated with Alzheimer's disease among Asians. Neurobiol Aging, in press.
7. Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, Ronald J, Blangero J, Hutton M, Younkin SG (2000) Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290, 2303-2304.
8. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
9. Ramirez Lorca R, Boada M, Saez ME, Hernandez I, Mauleon A, Rosende Roca M, Martinez Lage P, Gutierrez M, Real LM, Lopez Arrieta J, Gayan J, Antunez C, Gonzalez Perez A, Tarraga L, Ruiz A (2009) GAB2 Gene does not modify the risk of Alzheimer's disease in Spanish APOE e4 carriers. J Nutr Health Aging 13, 214-219.
10. Sasieni PD (1997) From genotypes to genes: doubling the sample size. Biometrics 53, 1253-1261.
11. Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L (2008) Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 65, 45-53.